Tempus AI is trading higher despite broader U.S. markets moving lower on September 24, 2026; no company-specific catalyst was identified.
- Trading at $80.09 (+4.57%).
- Recent attention followed the September 21 Recursion agreement, extending collaboration through November 2029 and adding an RNA model license.
- The move appears unusual versus the S&P 500, Nasdaq, and Dow, all lower; attribution remains uncertain.